Company: CERO
Filing Date: 2025-01-21
Form Type: S-1/A
Source: 0001213900-25-004742
Chunk: 104

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-21
Form: S-1/A
Chunk 104
---
 Common Stock issuable upon the         
 exercise of public warrants to purchase shares of our Common Stock, at an exercise price of $1,150.00 per share, that were originally      
 issued in the Initial Public Offering; and                                                                                                 |

| ● | a registration statement                                                                                                                 
 with the SEC for purposes of registering of the resale from time to time of up to 6,385,638 shares of Common Stock, which consists       
 of (i) 576,710 shares of Common Stock issuable upon the conversion of shares of our Series A Preferred Stock purchased by certain        
 investors pursuant to the First Securities Purchase Agreement; (ii) 91,829 shares of Common Stock issuable upon the conversion of        
 shares of our Series B Preferred Stock purchased by certain investors pursuant to the Second Securities Purchase Agreement; (iii)        
 707,394 shares of Common Stock issued upon the conversion of shares of our Series A Preferred Stock and Series B Preferred Stock;        
 (iv) 4,366,837 shares of Common Stock issuable upon the conversion of 300% of the number of outstanding shares of our Series C Preferred 
 Stock purchased by certain investors pursuant to the Third Securities Purchase Agreement; (v) 2,500 shares of Common Stock issued        
 to a stockholder in a reallocation of shares in connection with the consummation of the Business Combination; (vi) 81,752  shares        
 of Common Stock issuable upon the exercise of warrants to purchase shares of our Common Stock, at an exercise price of $9.80 per         
 share, which warrants were sold to certain investors pursuant to the Third Securities Purchase Agreement (the “Series C Warrants”);      
 and (ii) 558,617 shares of Common Stock issuable upon the conversion of shares of Series A Preferred Stock resulting from the exercise   
 of outstanding Series A Preferred Warrants.                                                                                              |

56 In addition to any resales pursuant to such registration statements, subject to applicable transfer restrictions and the conditions to the availability of Rule 144 for former shell companies under Rule 144(i), shares of Common Stock held by these stockholders will be eligible for resale, potentially subject to, in the case of stockholders who are our affiliates, volume, manner of sale, and other limitations under Rule 144 promulgated under the Securities Act. In addition, shares of our Common Stock issuable upon exercise or vesting of incentive awards under our incentive plans are, once issued, eligible for sale in the public market, subject to any lock-up agreements and